Imexpharm (IMP.VN) Stock Price
Imexpharm Price
Revenue has compounded at 8.4% per year over the past 19 years to 2.44 T VND. Earnings per share have grown at 1.3% per year over the last 19 years. Imexpharm's net margin stands at 14.3%, broadly stable from 14.9% several years earlier. Imexpharm currently offers a dividend yield of about 1.40%. The payout ratio is around 22% of earnings. Analysts set a median price target of 54,570.00 VND, implying 53.3% above the current price. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Imexpharm stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Imexpharm business model & stock analysis
Frequently asked questions about Imexpharm
Analysts currently set an average price target of 54,264.00 VND for the Imexpharm stock (median: 54,570.00 VND), implying +51.8 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Imexpharm stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Imexpharm to generate revenue of 2.91 T VND and earnings per share of 2,527.36 VND.
Converted at the current exchange rate, the Imexpharm share trades at 1.23 EUR (35,600.00 VND).
The expected revenue of Imexpharm is 2.91 T VND. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Imexpharm is 389.24 B VND. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Imexpharm is currently 14.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Imexpharm stock.
The price-to-sales ratio (P/S) of Imexpharm is currently 1.89. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Imexpharm stock.
The Eulerpool Quality Score for Imexpharm is 7/10.
The ISIN of Imexpharm is VN000000IMP0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Imexpharm is IMP.VN. The ticker symbol is used to trade Imexpharm shares on the stock exchange.
Imexpharm stock
Imexpharm Peer Group
Imexpharm FIGI
All fundamentals and in-depth analysis of Imexpharm
Our stock analysis for Imexpharm stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Imexpharm. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.